Exelixis Inc. Common Stock vs Franklin FTSE South Korea ETF — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.83B). The key difference: Exelixis Inc. Common Stock is far larger — about 8× Franklin FTSE South Korea ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Franklin FTSE South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Franklin FTSE South Korea ETF for 15 Days on average.
| EXEL | FLKR | |
|---|---|---|
Market Cap | $14.62B | $1.83B |
Volume | 2,684,957 | 679,902 |
Sector | Health | Broad Market / Factor |
52-Week High | $59.13 | $72.25 |
52-Week Low | $34.54 | $27.09 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $13.95B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →